3 Naphthylisoquinolines
Naphthylisoquinoline alkaloids have been isolated from the following
plant species, the six marked with asterisks being new
alkaloids:
Ancistrocladus korupensis
26
korundamine A*
14Ancistrocladus
robertsonorium
27
ancistrobrevine B,
ancistrocladine, ancistrorobertsonine A*
15 and
hamatine
Triphyophyllum peltatum
28-30
dioncophylline D*
16a,
8-
O-methyldioncophylline D*
16b,
5

-
O-demethyldioncophylline A*
17a and
dioncophyllinol*
18.

Of
the new alkaloids the absolute stereochemistry of dionocophylline D was
determined by oxidation to
D-alanine and
(
R)-3-aminobutyric acid
28
and of
5

-
O-methyldioncophylline A by an X-ray crystallographic
study of its 5-bromo-
N,O,O-tribenzyl derivative and by partial
synthesis from dioncopeltine A.
29
The
absolute configurations of the known isoancistrocladine
19 and its
rotamer, isohamatine, have been determined from their CD spectra.
31
Dionocophyllinol is the first
4-hydroxytetrahydroisoquinoline reported in this series, and korundamine A
is the first unsymmetrical dimer of a 5-naphthyl and a
7-naphthylisoquinoline. The latter alkaloid shows antiviral activity
against HIV-1 and antimalarial activity against
Plasmodium
falciparum.
26
Michellamines A, B and C
and korupensamines A and B have been separated by HPLC, and the enzymatic
oxidation of korupensamine B to michellamine C has been confirmed.
32

The
bromo-acid
20 and the phenol
21 have been coupled through
the ester
22 to give the lactone
23a, which was converted
through
23b into dioncolactone A
23c. Reduction of
23b with the complex of borane and the
(
S)-oxazaborolidine
24 afforded over 95% enantiomeric
excess of
N-benzyldioncopeltine A, easily converted into
dioncopeltine A
17b and into
5

-
O-dimethyldioncophylline A
17a. The unwanted
atropomer produced in the reduction of
23b was easily converted
back into
23b for further use.
33
Using a similar approach the lactone
25 was reduced to the alcohol
26, from which the naphthalene system was constructed to afford a
synthesis of korupensamines A and B
27,
34
which have also been synthesised by the
palladium-mediated coupling of the bromo-compound
28 with the
boronic acid
29, followed by removal of the protecting benzyl
group.
35

Octadehydromichellamine
32, which contains no
asymmetric carbon atom, is not preparable by the dehydrogenation of
michellamines A, B or C, but has been synthesised by the coupling of
30, available from previous syntheses of michellamines, with the
boronic acid
31. It shows antiviral and cytotoxic activity against
HIV-1 of the same order as that of michellamine B, but its activities
against both chloroquine-resistant and chloroquine-sensitive strains of
Plasmodium falciparum are significantly greater than those of the
alkaloid.
36
Other syntheses of alkaloids of
this group have been reviewed.
37
8 Berberines and tetrahydroberberines
Alkaloids of the berberine group have been isolated from the following
plant species, the four marked with asterisks being new
alkaloids:
Anomianthus dulcis
1
capaurine, caseamine and discretamine
Berberis
turcomanica
38
N-methylcorydaline chloride
Berberis
vulgaris
19
berberine, 8-oxyberberine,
jatrorrhizine and palmatine
Croton hemiargyreus
89
hemiargyrine*
52Enantia
chlorantha
90
hydroxydihydropalmatine*
53Fissistigma balansae
91
columbamine, dehydrodiscretamine, fissiaine*
54, kikemanine and thaipetaline
Fumaria agraria
92
coptisine, palmatine, sinactine, stylopine and
N-methylstylopine chloride
Fumaria bastardii
20
stylopine and tetrahydropalmatine
Fumaria
capreolata
92
coptisine, sinactine and
stylopine
Fumaria densiflora
92
coptisine, palmatine, sinactine, stylopine and
N-methylstylopine chloride
Fumaria muralis
92
coptisine, palmatine, sinactine and
stylopine
Fumaria officinalis
92
coptisine, palmatine, sinactine, stylopine and
N-methylstylopine chloride
Fumaria parviflora
92
coptisine, sinactine, stylopine and
N-methylstylopine chloride
Fumaria vaillantii
92
coptisine, palmatine, sinactine and
stylopine
Phellodendron amurense
93
berberine
Stephania rotunda
94
tetrahydropalmatine
Thalictrum
przewalskii
22
berberine and
pseudocoptisine
Tinospora hainanensis
95
N-methyltetrahydrocolumbamine chloride*
55

In addition 8-trichloromethyldihydroberberine
56a
and 8-trichloromethyldihydropalmatine
56b, which are presumed to
be artifacts of the solvent extraction process, have been isolated from
Berberis oblonga and
Berberis integerrima.
96
The structures of these
96
and of tetrahydropalmatine hydrate
94
were confirmed by X-ray crystallographic
studies.

Govadine
57a has been synthesised by the
photo-catalysed cyclisation of
58,
97
and bharatamine
57b has been
synthesised in the same way from the simpler
59.
98
Cyclisation of the acetylenes
60a and
60b has afforded the macrocyclic lactams
61 and
62 respectively, both of which were stereospecifically cyclised by
hydriodic acid to the oxyberberine analogue
63 in very good yield.
In marked contrast with this the cyclisation of
60b with
tetrabutylammonium fluoride gave a quantitative yield of the
isoindolobenzazepine
64, which is an analogue of the alkaloid
lennoxamine (section 13).
99
The silylated
lactam
62 has been oxidised by the dimethyldioxirane
65a
to the epoxide
66, which was cyclised by hydrochloric acid to the
unsaturated lactam
67. The same sequence of reactions with the
unsilylated lactam
61 afforded the hydroxylated lactam
68. The (
Z)-isomer of the (
E)-lactam
61
reacted more sluggishly with an excess of the oxidising agent
65a,
eventually giving a mixture of the tetrahydroberberine
69 and the
isoindolobenzazepine
70, which are analogues of the alkaloids
prechilenine and chilenine respectively. Oxidation of
62 with
65a involved some fission of the veratrole ring to give
71 in addition to
66, but the bulkier dioxirane
65b was unable to attack the styrenoid double bond and only the
diester
72 was obtained.
100

The pharmacological properties and physiological effects of
berberine,
101-103
of
palmatine,
104,105
of
tetrahydropalmatine,
106
and of
stepholidine
106-108
have been studied, and the synthetic berberine
73 and its close
analogues have been tested as potential antimicrobial agents.
109
13 Other modified berberines
Chilenine has been isolated from
Berberis vulgaris
19
and a new alkaloid, leptocarpinine, which has
been assigned the arylbenzazepine structure
78 on the basis of its
spectra, has been isolated from
Hypercoum leptocarpum.
21
Apart from the additional methylene group,
78 has the skeleton of a hydrolysed chilenine
79 and
might be expected to be derived from a secoberberine alkaloid in a manner
similar to the derivation of chilenine from berberine. However the
orientation of substituents in
78 and
79 is different and
the substitution pattern of any putative precursor of
78, such as
80, which could be converted into
78 through
81
and
82, is observed only in the alkaloid caseadine
83.
The very much more common 2,3,9,10-substitution pattern is observed in all
of the alkaloids (protopine
84, isohyperectine
85,
leptopine
74a, leptopinine
74b, leptopidine
75
and leptopidinine
76) isolated together with leptocarpinine, from
Hypecoum leptocarpum suggesting that this alkaloid more probably
has the structure
86. Structures deduced entirely from spectra
have occasionally had to be revised, most recently those of fumarizine and
dehassiline. Though 13a
C-methylated tetrahydroberberines have not
so far been reported, alkaloids with
C-methyl groups in the other
benzylic positions 8 and 13 are known and the introduction of such a group
into
80 or an isomer presents no biogenetic problem.

The acetylenic amide
87 has been cyclised to the
isoindole
88, oxidation of which gave the vicinal diol
89a, the monomethyl ether of which
89b was cyclised to
the isoindoloquinoline
90. Rearrangement of this afforded
dehydrolennoxamine
91, which was hydrogenated to lennoxamine
92.
118
The synthesis of analogues
of chilenine and lennoxamine from macrocyclic acetylenes is reported in
section 8.
14 Benzophenanthridines
Chelilutine and chelirubine chlorides
93a and
93b have
been converted into the bimolecular alkanolamine ethers
94a and
94b by aqueous sodium carbonate and into the bimolecular amines
95a and
95b by aqueous ammonia. The simple alkanolamines
96a and
96b have been detected only in solutions of the
alkaloids in deuteriochloroform on shaking with aqueous sodium
carbonate.
119
The NMR spectrum of
6-hydroxydihydrosanguinarine
96c, obtained in deuteriochloroform
in the same way from sanguinarine, has been studied.
120

The assignment of structures
99a and
99b
to fagaridine and isofagaridine respectively has been confirmed by detailed
studies of their UV spectra
121
and by
syntheses of both alkaloids by internal aryl-aryl couplings of
97a and
97b in the presence of tri-
n-octyltin
iodide to give
98a and
98b, followed by oxidation to the
related isoquinolines with manganese dioxide and
N-methylation.
121,122
Similar aryl-aryl cyclisations of the trifluoromethane sulfonates
100a,
100b and
100c by palladium(
II)
acetate, 3-bis(diphenylphosphino)propane and tributylphosphine have
afforded dihydrochelerythrine
101a, dihydronitidine
101b
and oxonitidine
101c, which were converted into chelerythrine
99c and nitidine
99d.
123,124

An alternative approach, using the Suzuki coupling of an
aryl halide with an arylboronic acid, used so successfully in the synthesis
of naphthylisoquinoline alkaloids, has afforded a range of
benzophenanthridine alkaloids. The required 2-bromo-1-aminonaphthalene was
difficult to prepare, but was finally obtained from the 1-tetralone
102a by bromination to
102b and dehydrobromination to the
2-bromo-1-naphthol
103a, followed by Smiles rearrangement of the
ether
103b to the amide
104a, which was hydrolysed to the
amine
104b. This was found to react only sluggishly and
inefficiently with the aldehydic boronic acids
105a and
105b, in attempts to generate the tetracyclic system directly, but
the formamide
104c and the simpler boronic acids
106a and
106b readily coupled to give good yields of
107a and
107b. These were then subjected to Bischler-Napieralsky ring
closure to give nornitidine
108a and noravicine
108b.
N-Methylation of
107a and
107b gave
107c and
107d and cyclisations of these afforded nitidine
99d and avicine
99e. Similar syntheses of chelerythrine
99c and chelilutine
93b were achieved from the boronic
acids
109a and
109b and the amide
104c.
125

The 4-phenylisoquinoline alkaloid decumbenine B
116,
126
which can be regarded as
a degraded benzophenanthridine, has been synthesised from piperonal, the
lithium salt of which
110a, when treated with ethyl chloroformate
yielded
110b. Protection of the aldehyde group of this as the
cyclic dithioketal, followed by reduction of the ester with lithium
aluminium hydride and hydrolysis of the ketal, afforded
110c,
which was benzylated to give
110d. Condensation of this with
benzylamine yielded the imine
111, to which the anhydride
112 added to give the lactam
113. This was decarboxylated
to
114a and the protecting groups were then removed to give
114b, which was reduced to the amine
115, dehydrogenation
of which gave decumbenine B
116.
127

The pharmacological properties and physiological effects of
chelerythrine
128
and the binding of
fagaronine to DNA
129
have been studied
15 Aporphinoid alkaloids
15.1 Proaporphines
Proaporphine alkaloids have been isolated from the following plant
species:
Annona cherimola
17
pronuciferine
Anomianthus dulcis
1
pronuciferine and stepharine
Orophea
hexandra
39
N-methylcrotonosine
and pronuciferine.
15.2 Aporphines
Aporphine alkaloids have been isolated from the following plant species,
the five marked with asterisks being new alkaloids:
Annona
cherimola
17
norisocorydine,
norstephalgine and romucosine
Annona purpurea
130
lirindine,
N-methyllaurotetanine,
norpurpureine, thalicmidine, 7-hydroxydehydrothalicsimidine*
117a
and
N-formyl-7-hydroxydehydronorthalicsimidine*
117bAnomianthus dulcis
1
anonaine, anolobine, asimilobine, isoboldine,
N-methyllaurotetanine, nornuciferine and roemerine
Berberis
vulgaris
19
magnoflorine
Cassytha
filiformis
131
actinodaphnine,
N-methylactinodaphnine, cassythicine, cathafiline, cathaformine,
ocoteine, and predicentrine
Croton hemiargyreus
89
glaucine
Fissistigma balansae
132
fissilandione*
118a and
norfissilandione*
118bGlaucium fimbrilligerum
133
bulbocapnine

-
N-oxide*
119Elastostema sinuata
134
procoteine, thalicsimidine, thaliporphine and
wilsonirine
Thalictrum przewalskii
22
magnoflorine and
N-methylnantenine
Thalictrum triternatum
111
glaucine, thalfine and thalmine

The new quinones
118a and
118b are analogues of
isocorydione
120a and norisocorydione
120b, previously
isolated from
Dehassia tetrandra,
135
and can be prepared in a similar manner to
these alkaloids, from the related phenols,
N-methylfissolidine
121a and fissolidine
121b, by oxidation with
Fremy

s salt.
132

The rearrangement of morphine by concentrated sulfuric acid
in the presence of 4-dimethylaminobenzaldehyde has given the apomorphine
derivative
122, available in the same way from apomorphine
123.
136
Apomorphine and acetone
afford the cyclic ketal
124, which has been reduced by
trimethylaluminium to the phenol
125a, the trifluoroacetate of
which
125b on hydrogenation over palladium yielded
126a,
which was cleaved to 10-hydroxyaporphine
126b.
137
The alternative cleavage of
124 to
give 11-hydroxyaporphine
127 has also been accomplished.
138

Cyclisation of the halogenated benzyldihydroisoquinolinium
salts
41a-
41c to the aporphine dehydroroemerine is
reported in section 4. The olefins
128a-
128c have
been cyclised by Lewis acids to the tetrahydroaporphines
129a-
129c.
139

The pharmacological properties and physiological effects of
apomorphine
140-144
of actinodaphnine,
131
of
N-methylactinodaphnine
131
of bulbocapnine,
145,146
of bracteoline,
147
of cassythicine
131
of cathafiline,
131
of cathaformine,
131
of dehydroglaucine,
147
of 7-acetyldehydroglaucine,
147
of 7-benzoyldehydroglaucine,
147
of 7-formyldehydroglaucine,
147
of 7-formyldehydrothalicsimidine,
130
of 7-hydroxydehydrothalicsimidine,
130
of isoboldine,
147
of ocoteine,
131
and of predicentrine
131
have been studied, and a patent claiming
9-
O-ethylboldine
130 and its analogues as inhibhitors of
metalloproteinases has been published.
148
15.3 Phenanthrenes
A synthesis of the alkaloid taspine which, though not itself a
phenanthrene, is regarded as an oxidised member of this group, has been
effected. Treatment of the substituted benzamide
131a with
butyllithium and iodine gave
131b, which was coupled over copper
powder to the biphenyl
132, and this was hydrolysed and cyclised
to the dilactone
133a. Iodination of this yielded
133b,
which reacted with allyltributyltin and
tetrakis(triphenylphosphino)palladium to give
134, and this on
ozonolysis furnished the aldehyde
135 which, on reductive
amination with dimethylamine, yielded taspine
136.
149
15.4 Oxoaporphines
Oxoasimilobine and oxoglaucine have been isolated from
Annona
cherimola
17
and from
Croton
hemiargyreus
89
respectively. The
pharmacological properties of oxoglaucine have been studied.
147
15.5 Dioxoaporphines
The new dioxoaporphine alkaloid aristoliukine B
137 and the
known alkaloid cepharadione A have been isolated from
Aristolochia
kaempferi
150
and from
Piper
augustum
151
respectively.
15.6 Aristolochic acids
The aristolochic acids
138a,
138b and
138c
have been isolated from
Aristolochia foveolata
152
and claimed to be new compounds, but acids of
these structures have previously been reported as aristolochic acid
A,
153
aristolochic acid C
154
and 7-hydroxyaristolochic acid A.
155
New esters of aristolochic acid-II and
aristolochic acid A with complex alcohols have been isolated from
Aristolochia heterophylla
156,157
as aristophyllide A
139a, aristophyllide
B
140a, aristophyllide C
139b, aristophyllide D
140b, aristoterpenate-I
141a, aristoterpenate-II
141b, aristoterpenate-III
142a and aristoterpenate-IV
142b. The configurations of these at the asymmetric carbon atoms
were determined from their CD spectra. The terpenoid esters
141
and
142 showed cytotoxic activity against hepatoma G cells.
157

Seven phenanthrene-1-carboxylic acids, which may be
degraded aristolochic acids, have been isolated from
Aristolochia
curcurbitifolia.
158
15.7 Aristolactams
Aristolactams have been isolated from the following plant species, the
six marked with asterisks being reported for the first
time:
Aristolochia contricta
159
4-
O-methylaristolactam A-IIIa
N-

-
D-glucoside*
143a,
4-
O-methylaristolactam A-IIIa
N-

-
D-(6-
trans-coumaroyl)glucoside*
144, aristolactam B-III
N-

-
D-glucoside*
143b and
O-demethylaristolactam A-IIIa
N-

-
D-glucoside*
145Aristolochia
kaempferi
150
aristoliukine A*
(3-
O-demethylaristolactam C-II)
146Piper
augustum
151
cepharanone B and
N-methylpiperolactam B*
147Piper
tuberculatum
160
cepharanone B

The aglycones of
143a and
145 have not been reported
as free aristolactams.
16 Alkaloids of the morphine group
Alkaloids of the morphine group have been isolated from the following
plant species, the two marked with asterisks being new alkaloids:
Croton
hemiargyreus
89
salutaridine and
norsalutaridine
Elastostema sinuata
134
amurine
Menispermum dauricum
161
dechloroacutumine*
149bPachygone
dasycarpa
162
14-hydroxyisostephodeline*
148

Dechloroacutumine
149b was only isolated from
Menispermum dauricum grown in chloride-free media. In the presence
of chloride ion only acutumine
149a is produced.
161

The
O-demethylation of codeine to morphine has been effected in
91% yield with boron tribromide and in 73% yield using L-Selectride. The
latter reagent has also proved effective (30%) in the more sensitive
demethylation of thebaine
151 to oripavine and in the
demethylation of 14-hydroxycodeinone and of
O-methylnaltrindole.
163
Codeine
has been converted into thebaine
151 by oxidation to codeinone
150, followed by enol methylation;
164
it has also been rearranged by butyllithium to
thebainone A
152 in 74% yield, which is much superior to earlier
yields by rearrangement over palladium.
165
The acid-catalysed condensation of morphine with paraformaldehyde has been
shown to give a mixture of the 1,1

-methylenebis-compound
153 and the bases
154a and
154b.
166
Ethers of 1,2

-dimorphine and of
trimorphine and tetramorphine have been obtained by the oxidation of
morphine 3-ethers with potassium ferricyanide.
167

Dihydrocodeinone
155a on treatment with
diaryliodonium iodides affords the 7

-aryl and
7,7-diaryldihydrocodeinones
155b and
155c,
168
and has been converted by the Wittig reaction
into the olefins
156a-
156e. Of these
156b
and
156c were hydrolysed to the aldehyde
157, which
readily suffered base-catalysed cleavage of the oxygen bridge to give the
phenol
158, and
156d and
156e on catalytic
reduction afforded a mixture of
159 and
160, though the
non-phenolic dihydro compound
161 was obtained by reduction with
diimide. Attempts to prepare the olefins
156f and
156g by
the Wittig reaction resulted in a mixture of the dienes
162 and
163 and in production of the phenolic dimer
164
respectively, and use of the ylide from isopropyltriphenylphosphonium
bromide resulted in the formation of the aldol
165.
169

6-Bromodihydrocodide
166 has been converted by
tributyltin hydride into a mixture of deoxycodeine C
167 and
dihydrodeoxycodeine D
168,
169
and
the same reagent has been used to cyclise
6-
O-(2-bromophenyl)isocodeine
169 to the dibenzofuran
170.
170
Morphine reacts with
4-dimethylaminobenzaldehyde in the presence of perchloric acid to give the
triarylmethane derivative
171, but in concentrated sulfuric acid
the reaction leads to the apomorphine derivative
122.
136

5-Methylthebaine reacts with trifluoroacetaldehyde to give
the 14-substituted codeinone
173, presumably by way of the
Diels-Alder adduct
172, and this has been epoxidised with
alkaline hydrogen peroxide to
174, which gave
175 on
reduction with sodium borohydride.
171
The
Diels-Alder adducts of thebaine
176a-
176d and
their 6,14-
endo-ethano analogues have been equilibrated with their
C-7 epimers by non-nucleophilc bases in dipolar aprotic solvents, the
equilibrium in all cases favouring the 7

epimers. The 7

epimer
of
176c has been reacted with phenylmagnesium bromide to give the
dimeric base
177.
172
The adduct
176b has been rearranged by chromium iminodiacetate to the
dihydro-8,14-cyclopentathebaine
178.
173
It has been shown that the acid-catalysed
rearrangement of alcohols of structure
179 to tetrahydrofurans
180 proceeds with retention of configuration at C-7.
174
This has been held to vitiate the mechanism
originally proposed for this reaction
175
but nothing in that mechanism necessarily requires scrambling at this
centre. X-Ray crystallographic studies of the alcohol
181 and its
C-7 epimer have confirmed their structures.
176

In Diels-Alder reactions other than those of thebaine
the diene
182, prepared from 6-
O-trifluoroacetylcodeine
and tri- butylvinyltin, afforded poor yields of the adducts
183
and
184 with tetracyanoethylene and diethyl acetylenedicarboxylate
respectively.
170

Details of the preparation of the following have been
published: the 14-aminodihydrocodeinone derivatives
185a-
185c,
177
N-benzyl-14-hydroxydihydronormorphinone,
178
14-
O-benzylnaltrexone,
179
3-deoxy-14-
O-benzylnaltrexone,
179
the 7-arylidenenaltrexones
186a-
186k,
180
the
indole
187a, the benzofuran
187b and related
compounds,
181-184
the quinolines
188a-
188d and related bases,
185
the diamine
189 and related
bases,
186
the amide
190,
187
buprenorphine,
188
4,5-deoxythebaine
191 and its
analogues,
189
ethers of morphine and of
14-hydroxymorphine,
190,191
14-hydroxydihydromorphinone, 14-hydroxydihydrocodeinone and their
derivatives,
192
3H-labelled
morphine and codeine
193
and
18F-labelled naltrindole.
194

The bacterial oxidation
195
and the gluronidation
196
of morphine and
of codeine and methods for the detection and estimation of morphine,
197-201
of
codeine
201,202
of
6-
O-methylcodeine,
202
of
thebaine
202
and of buprenorphine
203
have been studied, and the crystal structure
of the complex of morphine and (
S)-2-phenylhydracrylic acid has
been examined.
204
The hydrogenation of
methyl pyruvate in the presence of dihydrocodeine or of thebaine has been
found to favour the formation of an excess of the (
S)-lactate,
whereas in the presence of 14-hydroxydihydrocodeinone or of naloxone an
excess of the (
R)-lactate is formed.
205

An asymmetric synthesis of (

)-dihydrocodeinone (and hence a
formal synthesis of morphine) has been achieved from
5-chloro-7,8-dimethoxy-1-tetralone. Claisen condensation of this with ethyl
formate afforded
192, which, with methyl vinyl ketone followed by
retro-Claisen cleavage, yielded racemic
193, together with 10% of
the achiral
194, which could be separately equilibrated with
193. Racemic
193 gave
193 on resolution by
chromatography on cellulose triacetate and the unwanted enantiomer was
easily converted into the equilibrium mixture of racemic
193 and
194 for further use. Reaction of
193 with
vinylmagnesiocuprate gave
195a in very good yield and bromination
of this gave
195b, which was cyclised to
196 in
dimethylformamide at 140 °C. The cyclic ketal of this ketone on
hydroboration and oxidation afforded the alcohol
197a, reduced to
197b and this was converted directly into
198 by
N-methylbenzenesulfonamide. Bromination of
198 with
N-bromosuccinimide and dehydrobromination of the product afforded
the olefin
199, which was cyclised to
200, and hydrolysis
of this ketal yielded (

)-dihydrocodeinone
155a.
206

(+)-Cepharamine, the mirror image of the natural alkaloid,
has been synthesised for pharmacological screening in comparison with
morphine, which has the same absolute stereochemistry. Alkylation of the
Birch reduction product of
201 with the halide
202 gave
the enol ether
203, which was hydrolysed, reduced and cyclised to
the lactone
204a. The formyl ester of this
204b was
oxidised to the enone
205a, which was ketalised and cyclised by
tributyltin hydride to
205b. The derived
205c was then
subjected to Hofmann rearrangement to
206 and this was reduced
with lithium aluminium hydride to the cyclic amine
207. Oxidation
of this to
208 and conversion into the enol ether afforded
209, which was hydrolysed to (+)-cepharamine
210.
207

Approaches to the synthesis of compounds of the morphine,
morphinan and hasubonine groups have been reviewed.
208

The analgesic properties,
209-260
metabolism
261
and pharmacokinetics
229,262-265
of morphine have
been studied, as have the effects of the alkaloid on behaviour,
266-270
on
immune responses,
271-278
on locomotor activity,
279-281
on the brain
282
on the cardiovascular system,
283,284
on the gastro-intestinal
tract,
285,286
on
respiration,
287,288
on
neurones,
289
on spinal receptors,
290
on the jaw reflex,
291
on appetite,
279
on post-operative recovery,
292
on the hippocampus,
293,294
on the newborn,
295,296
on the progression of sepsis,
297
of inflammation
298
and of fever,
299
on the activation of neutrophils,
300
on the activity of lymphocytes,
301
on levels of cholecystokinin,
302,303
of dopamine,
304
of enkaphalins,
305
of oxytocin,
306
of adenylcyclase,
307
and of intracellular calcium
308
and on the effects of amphetamine
309
and of lignocaine.
310
The effects of diazepam on the development of
tolerance to morphine have also been studied.
311

The narcotic antagonist actions of naloxone
312-317
and the effects of this
compound on behaviour,
318-323
on the cardiovascular system,
324
on immune responses,
325
on temperature,
326
on arterial gas concentrations,
327
on platelets,
328
on the effects of acute alcohol
poisoning,
329,330
on levels of
adrenocorticotrophin,
331
of
calcitonin,
332
and of endothelin-I,
332
on the relief of testicular torsion,
333
on the gastro-intestinal tract,
334
and on the effects of
(

)-clausenamide
335
have been
studied.

The pharmacological properties and physiological effects of the
following have also been studied: 3,6-
O,O-diacetylmorphine
(heroin),
230,336-339
morphine 3-glucuronide,
265,340
morphine 6-glucuronide,
222,230,237,246,265,339,341,342
codeine,
247,343-347
codeine glucuronide,
348
dihydromorphinone glucuronide,
349
thebaine,
350
oripvine,
351
14-hydroxydihydrocodeinone,
346,352-354
naloxone methiodide,
324
naltrexone,
355-366
naltrexone methiodide,
367-369
7-benzylspiroindanylnaltrexone,
370
naltrexol,
366
naltrindole,
371,372
nalbuphine,
285,316,373-375
nalmefene,
376

-funaltrexamine,
377-380
norbinaltorphimine,
381
14-hydroxymorphindole,
382
buprenorphine,
233,313,357,383-393
dihydroetorphine,
394
sinomenine,
395
and stephodeline.
396
17 Colchicine and related alkaloids
The absolute configuration of colchicine has been further
confirmed.
397
A method for the hydrolysis
of colchicine to
N-deacetylcolchicine without isomerisation of the
tropolone system has been described.
398
Colchicine undergoes a Diels-Alder reaction with the acetylenic
dienophiles benzyne, dimethyl acetylenedicarboxylate and cyclooctyne to
give the 8,12-adducts
211a,
211b and
211c. In
marked contrast, ethylthiocochicide undergoes a [3 + 2] cycloaddition of
benzyne to the enol thioether system to give
212 (not isolated)
which suffers hydrogen shift and cleavage of the carbon-sulfur bond
to give
213.
399
Thiocolchicine
has been demethylated to
214a,
214b and
214c,
and of these
214a and
214b have been oxidised to the
1,4-quinone
215 and the quinomethane
216
respectively.
400
Colchicinoid and
isocolchicinoid compounds react with amidines in dry benzene to give
1,3-diazazulenes, of type
217 from ring deactivated compounds such
as colchicine and of type
218 from ring activated compounds such
as 9-tolylsulfonylisocolchicine.
401

Thiocolchicone
219 has been converted into the
lactams
220a and
220b by heating in benzene with
methylamine and butylamine respectively, whereas with aniline the product
was the simpler ketone
221, which was reduced to the racemic
alcohol
222, resolved through its
(

)-(1
S)-camphamate ester.
402,403
Colchicine has been converted into the colchicein-
amide
223a by heating with piperidine
404
and phenolic colchiceinamides of general
formula
223 have been prepared by the demethylation of
223b and claimed to form a new class of topoisomerase-II
inhibitors.
405
Complex ethers of
3-
O-demethylcolchicine
224a-
224d have been
prepared as potential pharmaceuticals.
406

The physiological effects of colchicine,
407-412
of analogues of colchicine,
413
of
colchiceine,
408
of colchemid
414
and of esters of the alcohol
222
402
have been studied.
|
1
|
|
A. Sinz, R. Matusch, L. Witte, T. Santisuk, S. Chaichana and V. Reutrakul, Biochem. Syst. Ecol., 1998, 26, 139 [Links]. |
|
2
|
|
N. K. Kalia, B. Singh and R. P. Sood, J. Nat. Prod., 1999, 62, 311 [Links]. |
|
3
|
|
A. B. Shabalaeva and K. M. Turdybekov, Izv. Minist. Nauki-Akad. Nauk. Kaz., Ser Khim., 1998, 41. |
|
4
|
|
J. Drabovicz, B. Dudzinski, M. Mikolajczyk, M. W. Wieczorek and W. R. Majzner, Tetrahedron: Asymmetry, 1998, 9, 171. |
|
5
|
|
A. Floes-Parra, P. Suárez-Moreno, S. A. Sánchez-Ruíz, M. Tlahuextl, J. Jaen-Gaspar, H. Tlahuextl, R. Sala-Coronado, A. Crux, H. Nöth and R. Contreras, Tetrahdron: Asymmetry, 1998, 9, 1661 [Links]. |
|
6
|
|
O. A. Nurklenov, A. M. Gazaliev, B. K. Suleimenov and M. Zh. Zhurinov, Russ. J. Gen. Chem., 1997, 67, 1946. |
|
7
|
|
G. W. Kunsman, R. Jones, B. Levine and M. L. Smith, J. Anal. Toxicol., 1998, 22, 310. |
|
8
|
|
R. J. Briscoe, S. A. Vaneck, M. Vallet, T. J. Baird, F. A. Holloway and D. V. Gauvin, Pharmacol. Biochem. Behav., 1998, 60, 695 [Links]. |
|
9
|
|
C. M. Meston and J. R. Heiman, Arch. Gen. Psychiatry, 1998, 5, 652. |
|
10
|
|
B. J. Gurley, S. F. Gardner, L. M. White and P. L. Wang, Ther. Drug Monit., 1998, 20, 439 [Links]. |
|
11
|
|
R. Young, M. Gabryszuk and R. A. Glennon, Pharmacol. Biochem. Behav., 1998, 61, 162 [Links]. |
|
12
|
|
D. K. Miller, L. R. McMahon, T. A. Green, J. R. Nation and P. J. Wellman, Psychopharmacology (Berlin), 1998, 140, 52. |
|
13
|
|
M. Y. H. Chow, K. M. Sim, A. T. Sia and Y. W. Chan, Int. Congr. Ser.-Excerpta Med., 1998, 1164, 301. |
|
14
|
|
B. Ouyang, S. Li and J. Long, Hunan Yixue, 1998, 15, 288. |
|
15
|
|
D. Yuan, K. Komatsu, Z. Cui and Y. Kano, Biol. Pharm. Bull., 199, 22, 165. |
|
16
|
|
S. Helsley, D. Fiorella, R. A. Rabin and J. C. Winter, Proc. Neuro-Psychopharmacol. Biol. Psychiatry, 1998, 22, 649. |
|
17
|
|
C. Y. Chen, F. R. Chang, C. M. Teng and Y. C. Wu, J. Chin. Chem. Soc. (Taipei), 1999, 46, 77. |
|
18
|
|
I. I. Khamidov, S. F. Aripova, M. V. Telezhenetskya and A. K. Karimov, Khim. Prir. Soedin., 1996, 894(Chem. Abstr.199913030977. |
|
19
|
|
R. Suau, R. Rico, J. M. Lopez-Romero, F. Najera and A. Cuevas, Phytochemistry, 1998, 49, 2545 [Links]. |
|
20
|
|
N. Kucukboyaci, F. Bingol, B. Sener and J. P. Kutney, Nat. Prod. Sci., 1998, 4, 257. |
|
21
|
|
Z. Yi, G. Zhang and B. Li, Phytochemistry, 1999, 50, 339 [Links]. |
|
22
|
|
A. J. Al-Rehaily, M. N. M. Sharaf, M. A. Zemaitis, C. Y. Gao, G. E. Martin, C. E. Hadden, T. J. Thaman, F. T. Lin and P. L. Schiff, J. Nat. Prod., 1999, 62, 146 [Links]. |
|
23
|
|
F. Abd El-Mageed Hashem and S. Ahmed Elsawi, Pharm. Pharmacol. Let., 1998, 8, 167. |
|
24
|
|
T. M. A. Alves and C. L. Zani, Tetrahedron Lett., 1999, 40, 205 [Links]. |
|
25
|
|
M. Chrzanowska and A. Sulima, Pol. J. Chem., 1998, 72, 2202. |
|
26
|
|
Y. F. Hallock, J. H. Cardellina, M. Schaffer, G. Bringmann, G. Francois and M. R. Boyd, Bioorg. Med. Chem. Lett., 1998, 8, 1729 [Links]. |
|
27
|
|
G. Bringmann, F. Teltschik, M. Schaffer, R. Haller, S. Bar, S. A. Robertson and M. A. Isahakia, Phytochemistry, 1998, 47, 31 [Links]. |
|
28
|
|
G. Bringmann, M. Wenzel, M. Rübenacker, M. Schaffer, M. Ruckert and L. A. Assi, Phytochemistry, 1998, 49, 1151 [Links]. |
|
29
|
|
G. Bringmann, W. Saeb, R. God, M. Schaffer, G. Francois, K. Peters, E. M. Peters, P. Proksch, K. Hostettmann and L. A. Assi, Phytochemistry, 1998, 49, 1667 [Links]. |
|
30
|
|
G. Bringmann, M. Wenzel, M. Ruckert, K. Wolf, S. Busemann, M. Schaffer and L. A. Assi, Heterocycles, 1998, 47, 985. |
|
31
|
|
J. Fleischhauser, A. Koslowski, C. Repges, K. P. Gulden and G. Bringmann, Z. Naturforsch., A: Phys. Sci., 1998, 53, 993. |
|
32
|
|
G. Bringmann, M. Ruckert, J. Schlauer and M. Merderich, J. Chromatogr. A, 1998, 810, 231 [Links]. |
|
33
|
|
G. Bringmann, W. Saeb and M. Rübenacker, Tetrahedron, 1999, 55, 423 [Links]. |
|
34
|
|
G. Bringmann and M. Ochse, Synlett., 1998, 1294 [Links]. |
|
35
|
|
T. Watanabe and M. Uemura, Chem. Commun., 1998, 871 [Links]. |
|
36
|
|
G. Bringmann, M. Wenzel, T. R. Kelly, M. R. Boyd, R. J. Gulakowski and R. Kaminsky, Tetrahedron, 1999, 55, 1731 [Links]. |
|
37
|
|
M. A. Rizzacasa, Stud. Nat. Prod. Chem., 1998, 20, 407. |
|
38
|
|
I. I. Khamidov, S. F. Aripova, M. V. Telezhenetskya, M. K. Faskhutdinov, A. K. Karimov and I. D. Dzhepberov, Khim. Prir. Soedin., 1996, 885(Chem. Abstr.199913030976. |
|
39
|
|
A. Sinz, R. Martisch and L. Witte, Biochem. Syst. Ecol., 1999, 27, 111 [Links]. |
|
40
|
|
R. Suau, N. Posadas, M. V. Silva and M. Valpuesta, Phytochemistry, 1998, 49, 2551 [Links]. |
|
41
|
|
A. Watanabe and J. Kunimoto, Heterocycles, 1998, 48, 1623. |
|
42
|
|
Q. D. You, Chin. J. Chem., 1998, 16, 162. |
|
43
|
|
J. Wu, H. Chen, Q. Chen and K. Pang, Zhongguo Yaowu Huaxue Zazhi, 1998, 8, 137. |
|
44
|
|
H. Hosztafi, Med. Aromat. Plants Ind. Profiles, 1998, 3, 105. |
|
45
|
|
S. Kazan, Acta Neurol. Scand., 1998, 98, 354 [Links]. |
|
46
|
|
B. W. Brandon, S. K. Woelfel, A. Ference, B. Dayal, D. R. Cook and S. Kerls, J. Clin. Anesth., 1998, 10, 195 [Links]. |
|
47
|
|
J. R. Ortiz, J. A. Percaz and F. Carrascosa, Rev. Esp. Anestesiol. Reanim., 1998, 25, 242. |
|
48
|
|
K. S. Kim, Y. S. Chun, S. U. Chou and J. K. Suh, Anaesthesia, 1998, 53, 872 [Links]. |
|
49
|
|
J. A. Lim, Y. Choi, G. Pei and Q. B. Yi, Zhongguo Yaoli Zazhi, 1999, 20, 81. |
|
50
|
|
Y. M. Lee, M. H. Jin, H. S. Yong and D. M. Lee, Int. Congr. Ser.-Excerpta Med., 1998, 1164, 301. |
|
51
|
|
M. T. Carroll, R. K. Mirakhur, D. M. Lowry, K. C. McCourt and C. Kerr, Anaesthesia, 1998, 53, 1169 [Links]. |
|
52
|
|
T. Ogino, T. Sato, H. Sasaki, K. Sugama, M. Okada, H. Mitsuhashi and M. Marino, Nat. Med. (Tokyo), 1998, 52, 125(Chem. Abstr.1998129228073. |
|
53
|
|
J. Zhang, Q. Mao, N. Xu and J. Chen, Zhongcaoyao, 1998, 29, 243. |
|
54
|
|
H. He, J. P. Zhang and C. Y. Zhang, Zhongguo Shengwu Haxue Yu Fenzi Shengwu Xuebao, 1998, 14, 304. |
|
55
|
|
H. He, X. Sun, J. Zhang and C. Zhang, Beijing Yike Daxue Xuebao, 1997, 29, 326. |
|
56
|
|
X. Lin, C. N. Luo, P. Feng, S. X. Liu, L. W. Wang, S. S. Xie and P. G. Xiao, J. Chin. Pharm. Sci., 1998, 7, 25. |
|
57
|
|
H. Zhou, L. Wang, X. Hao, Y. Gao and W. Li, Zhongguo Yaolixue Tongbao, 1998, 14, 165. |
|
58
|
|
G. H. Zhang, Z. L. Cheng and J. H. Jiang, Zhongguo Yaoli Xuebao, 1998, 19, 497. |
|
59
|
|
S. Frusawa, F. Jianghong, T. Fujimura, S. Nakano, S. Nemoto, M. Takayanagi, K. I. Sasaki and Y. Takayanagi, Methods Find. Exp. Clin. Pharmacol., 1998, 20, 87. |
|
60
|
|
K. Nishikawa, J. I. Asaumi, S. Kawasaki, K. I. Shibuya, M. Kuroda, Y. Takeda and Y. Hiraki, Anticancer Res., 1998, 18, 1649. |
|
61
|
|
Y. Zhang, Y. Feng, K. Huang, H. Mao, F. Zeng and C. Hu, Zhongguo Yaolixue Tongbao, 1998, 14, 47. |
|
62
|
|
D. L. Guo, J. S. Xia, S. F. Gu, F. D. Zeng and C. J. Hu, Zhongguo Yaolixue Yu Dulixue Zazhi, 1998, 12, 253. |
|
63
|
|
J. Liu, R. Li, G. Liu and J. Wang, Yaoxue Xuebao, 1998, 33, 165. |
|
64
|
|
J. Liu, C. Gao, R. Li and G. Liu, Zhongguo Yaolixue Tongbao, 1998, 14, 18. |
|
65
|
|
J. Liu, R. Li and G. Liu, Zhongguo Yaoli Xuebao, 1999, 20, 21. |
|
66
|
|
S. U. Choi, S. H. Park, K. H. Kim, E. J. Choi, S. Kim, W. K. Park, Y. E. Zhang, H. S. Kim, N. P. Jung and C. O. Lee, Anti-Cancer Drugs, 1998, 9, 255 [Links]. |
|
67
|
|
H. S. Kim, Y. H. Zhang, M. K. Lee and L. H. Fang, Med. Sci. Res., 1998, 26, 475. |
|
68
|
|
H. S. Kim, Y. H. Zhang and Y. P. Yun, Planta Med., 1999, 65, 135 [Links]. |
|
69
|
|
S. Kobyashi, K. Inaba, I. Kimura and M. Kimura, Biol. Pharm. Bull., 1998, 21, 346. |
|
70
|
|
J. Chen, Z. Wu, S. Chen, G. Zhang and X. Gong, Zhongguo Yingyong Shenglixue Zazhi, 1998, 14, 30. |
|
71
|
|
Y. L. Xong, H. W. Wang and W. X. Yao, Zhongguo Yaolixue Yu Dulixue Zazhi, 1998, 12, 109. |
|
72
|
|
Y. T. Huang and C. Y. Hong, Cardiovasc. Drug Rev., 1998, 16, 1. |
|
73
|
|
K. K. Wong, Planta Med., 1998, 64, 663 [Links]. |
|
74
|
|
D. Liu, G. Li, Y. Cao, Z. Su, W. Wang and X. Wu, Zhongguo Zhongyao Zazhi, 1998, 23, 55. |
|
75
|
|
Y. Xiong, M. Zhang and W. Yao, Zhongguo Zuzhi Hu Xibao Huaxue Zazhi, 1998, 7, 198. |
|
76
|
|
H. G. Zhang, X. L. Qiao, M. L. Wang, F. Y. Xing and Q. Ma, Zhongguo Bingli Shengli Zazhi, 1998, 14, 50. |
|
77
|
|
J. Che, J. Zhang, F. Chen and Z. Qu, J. Chin. Pharm. Sci., 1997, 6, 143(Chem. Abstr.1999130148527. |
|
78
|
|
X. T. Li and Y. L. Wang, J. Chin. Pharm. Sci., 1998, 7, 94. |
|
79
|
|
C. Sun, L. Zhang and J. Wang, Zhongguo Yiyuan Yaoxue Xuebao, 1998, 18, 500. |
|
80
|
|
L. J. Ho, D. M. Chang, T. C. Lee, M. L. Chang and J. H. Lai, Eur. J. Pharmacol., 1999, 367, 389 [Links]. |
|
81
|
|
Z. F. Wang, K. Li and X. R. Xiao, Zhongguo Yaoli Xuebao, 1999, 20, 253. |
|
82
|
|
D. Yan, S. E. Pedersen and M. W. White, Neuropharmacol., 1998, 37, 251. |
|
83
|
|
S. Chung and J. H. Shin, Korean J. Physiol. Pharmacol., 1998, 2, 549. |
|
84
|
|
C. Godoy-Alcantar, M. I. Nelen, A. V. Eliseev and A. K. Yatsimirsky, J. Chem. Soc., Perkin Trans. 2, 1999, 353 [Links]. |
|
85
|
|
S. X. Qiu, C. Liu, S. X. Zhao and Z. C. Xia, Tetrahedron Lett., 1998, 39, 4167 [Links]. |
|
86
|
|
A. K. Sidjimov, J. N. Tawara, F. R. Stermtiz and C. D. Rither, Phytochemistry, 1998, 48, 403 [Links]. |
|
87
|
|
W. T. Chang, S. S. Lee, F. S. Church and K. C. S. Liu, Phytochemistry, 1998, 48, 119 [Links]. |
|
88
|
|
T. Sinohara, A. Takeda, J. Toda and T. Sano, Heterocycles, 1998, 48, 981. |
|
89
|
|
A. C. F. Amaral and R. A. Barnes, Phytochemistry, 1998, 47, 1145 [Links]. |
|
90
|
|
P. Wafo, B. Nyasse and C. Fontaine, Phytochemistry, 1999, 50, 279 [Links]. |
|
91
|
|
Y. C. Chia, F. R. Chang, C. M. Li and Y. C. Wu, Phytochemistry, 1998, 48, 367 [Links]. |
|
92
|
|
J. Sousek, G. Guedon, T. Adam, H. Bochorakova, E. Taborska, I. Valka and V. Simanek, Phytochem. Anal., 1999, 10, 6 [Links]. |
|
93
|
|
S. Yamaguchi, T. Kawamura, Y. Noro and T. Tanaka, Nat. Med. (Tokyo), 1998, 52, 452. |
|
94
|
|
P. Luger, M. Weber, N. X. Dung, L. D. Moi, T. T. Khoi and D. L. Phuong, Acta Crystallogr., Sect. C, 1998, 54, 1972. |
|
95
|
|
Y. Guo, K. Kojima, L. Liu, X. Fu, C. Zhao, K. Hatano, Y. Chen and Y. Ogihara, Chem. Pharm. Bull., 1999, 47, 287. |
|
96
|
|
I. I. Khamidov, B. Tashkhodzhaev, S. F. Aripova, M. V. Telezhenetskya and A. K. Karimov, Khim. Prir. Soedin., 1996, 889. |
|
97
|
|
Y. Hu, Q. Zhou and D. Bai, Zhongguo Yaowu Huaxue Zazhi, 1998, 8, 190. |
|
98
|
|
Y. Hu, Q. Zhou and D. Bai, Zhongguo Yaowu Huaxue Zazhi, 1998, 8, 24. |
|
99
|
|
G. Rodriguez, L. Castedo, D. Dominguez and C. Saa, Tetrahedron Lett., 1998, 39, 6551 [Links]. |
|
100
|
|
G. Rodriguez, L. Castedo, D. Dominguez, C. Saa, W. Adam and C. R. Saha-Möller, J. Org. Chem., 1999, 64, 877 [Links]. |
|
101
|
|
S. N. Wu, H. S. Yu, C. R. Jan, H. F. Li and C. L. Yu, Life Sci., 1998, 62, 2283 [Links]. |
|
102
|
|
X. D. Huang, H. S. Luo, B. P. Yu and J. Q. Tong, Huarren Xiaohua Zazhi, 1998, 6, 801. |
|
103
|
|
J. F. Wu and T. P. Liu, J. Chin. Pharm. Sci., 1998, 7, 33. |
|
104
|
|
L. Zhang, C. Zhao, G. Dong and P. Yang, Shanxi Daxue Xuebao, Ziran Kexueban, 1998, 21, 144. |
|
105
|
|
Y. L. Chang, S. Usami, M. T. Hsieh and M. J. Jiang, Life Sci., 1999, 44, 597 [Links]. |
|
106
|
|
X. Ge, H. Zhang and C. Bian, Yangzhou Daxue Zian Kexueban, 1998, 1, 49. |
|
107
|
|
X. X. Zhang, Z. T. Zhu and G. Z. Jin, Life Sci., 1998, 63, 537 [Links]. |
|
108
|
|
W. Zhang, J. Zhi, W. Guo, R. Zhao and G. Jin, Yaoxue Xuebao, 1998, 33, 721. |
|
109
|
|
K. Iwasa, D. W. Lee, S. I. Kang and W. Wiegrebe, J. Nat. Prod., 1998, 61, 1150 [Links]. |
|
110
|
|
M. Chrzanowska, J. Jozkowiak, M. D. Rozwadowska and A. Sukima, Pol. J. Chem., 1998, 72, 2399. |
|
111
|
|
L. Kintsurashvili and V. Vachnadze, Izv. Akad. Nauk. Gruz., Ser. Khim., 1997, 23, 171(Chem. Abstr.1999130322950. |
|
112
|
|
J. Marek, J. Dostal and J. Slavik, Collect. Czech. Chem. Commun., 1998, 63, 416 [Links]. |
|
113
|
|
M. Rahimizadeh, M. K. Hassanzedeh and M. Haerizadeh, Orient. J. Chem., 1998, 14, 212. |
|
114
|
|
M. Kuziemka-Leska, H. Car and K. Wisniewska, Pol. J. Pharmacol., 1998, 50, 15. |
|
115
|
|
F. Debarbieus, J. Brunton and S. Charpak, J. Neurophysiol., 1998, 79, 2911. |
|
116
|
|
J. W. Phillis, Brain Res., 1998, 807, 193 [Links]. |
|
117
|
|
M. Schuler, P. Muehlbauer, P. Guzzie and D. E. Eastmond, Mutagenesis, 1999, 14, 51. |
|
118
|
|
Y. Koseki, S. Kusano, H. Sakata and T. Nagasaka, Tetrahedron Lett., 1999, 40, 2169 [Links]. |
|
119
|
|
J. Dostal, J. Slavik, M. Potacek, R. Marek, O. Humpa, V. Sklenar, J. Tousek, E. De Hoffmann and R. Rozenberg, Collect. Czech. Chem. Commun., 1998, 63, 1045 [Links]. |
|
120
|
|
J. Dostal, R. Marek, J. Slavik, E. Taborska, M. Potcek and V. Sklenar, Magn. Reson. Chem., 1998, 36, 869 [Links]. |
|
121
|
|
T. Nakanishi and M. Suzuki, J. Nat. Prod., 1998, 61, 1263 [Links]. |
|
122
|
|
T. Nakanishi, M. Suzuki, A. Mashiba, K. Ishikawa and T. Yokotsuka, J. Org. Chem., 1998, 63, 4235 [Links]. |
|
123
|
|
T. Harayama, T. Akiyama, Y. Nakano and K. Shibaike, Heterocycles, 1998, 48, 1989. |
|
124
|
|
T. Harayama and K. Shibaike, Heterocycles, 1998, 49, 191. |
|
125
|
|
G. R. Green, I. S. Mann, M. V. Mulane and A. McKillop, Tetrahedron, 1998, 54, 9875 [Links]. |
|
126
|
|
J. S. Zhang, D. Y. Zhu and S. H. Hong, Phytochemistry, 1995, 39, 435 [Links]. |
|
127
|
|
J. S. Zhang, D. Y. Yu and S. H. Hong, Phytochemistry, 1995, 39, 435 [Links]. |
|
128
|
|
S. K. Lee, W. G. Qing, W. Mar, L. Luyeng, R. C. Mehta, K. Kanishi, H. S. Fong, C. W. W. Beecher, A. D. Kinghorn and J. M. Pezzuto, J. Biol. Chem., 1998, 273, 19829 [Links]. |
|
129
|
|
A. Ianoul, F. Fleury, O. Duval, R. Waigh, J. C. Jardillier, A. J. P. Alix and I. Nabiev, J. Phys. Chem. B, 1999, 103, 2008 [Links]. |
|
130
|
|
F. L. Chang, J. L. Wei, C. M. Teng and Y. C. Wu, Phytochemistry, 1998, 49, 2015 [Links]. |
|
131
|
|
Y. C. Wu, F. R. Chang, Y. C. Chao and C. M. Teng, Phytother. Res., 1998, 12, 1 [Links]. |
|
132
|
|
Y. C. Chia, F. Chang and Y. C. Wu, J. Nat. Prod., 1998, 61, 1430 [Links]. |
|
133
|
|
A. Shafiee, K. Morteza-Semnani and M. Amini, J. Nat. Prod., 1998, 61, 12 [Links]. |
|
134
|
|
A. Arbain, D. Permana, M. H. Mukhtar and M. V. Sargent, ACGC Chem. Res. Commun., 1998, 8, 41. |
|
135
|
|
S. S. Lee, C. K. Chen, I. S. Chen and C. H. Chen, J. Nat. Prod., 1996, 59, 55 [Links]. |
|
136
|
|
K. Goerlitzer, I. M. Weltrowski and V. Wray, Pharmazie, 1998, 53, 684. |
|
137
|
|
J. C. Kim, S. D. Bae, J. A. Kim and S. K. Choi, J. Heterocyl. Chem., 1998, 35, 531. |
|
138
|
|
J. C. Kim, S. D. Bae, J. A. Kim and S. K. Choi, Org. Prep. Proced. Int., 1998, 30, 352. |
|
139
|
|
G. J. Meuzelaar, E. Neeleman, L. Maat and R. A. Sheldon, Eur. J. Org. Chem., 1998, 2101 [Links]. |
|
140
|
|
S. Duty, B. Henry, A. R. Crossman and J. M. Brotchie, Exp. Neurol., 1998, 150, 223 [Links]. |
|
141
|
|
V. Matto, T. Skrebukhova and L. Allikmets, Methods Find. Exp. Clin. Pharmacol., 1998, 20, 329. |
|
142
|
|
K. H. M. McAllister and J. A. Pratt, Eur. J. Pharmacol., 1998, 353, 141 [Links]. |
|
143
|
|
V. Matto and L. Allikmets, Med. Sci. Res., 1998, 26, 499. |
|
144
|
|
R. Luthringer, G. Rinaudo, M. Toussaint, P. Bailey, G. Müller, A. Muzet and J. P. Macher, Neuropsychobiology, 1999, 39, 49. |
|
145
|
|
J. S. Shin, K. T. Kim and M. K. Lee, Neurosci. Lett., 1998, 244, 161 [Links]. |
|
146
|
|
J. S. Shin and M. K. Lee, Yakhak Hoechi, 1998, 42, 170. |
|
147
|
|
S. Philipov, N. Ivanovska and P. Nikolova, Pharmazie, 1998, 53, 694. |
|
148
|
|
H. W. Krell, F. Grams and A. Brunner, PCT Int. Appl.,
WO16441/1999 (Chem. Abstr., 1999, 130, 282215). |
|
149
|
|
T. R. Kelly and R. L. Xie, J. Org. Chem., 1998, 63, 8045 [Links]. |
|
150
|
|
T. S. Wu, Y. L. Leu and Y. T. Chan, Chem. Pharm. Bull., 1998, 46, 1624. |
|
151
|
|
A. W. Delgado, M. E. Auvella and A. M. P. De Diaz, Rev. Colomb. Quim., 1998, 27, 13. |
|
152
|
|
Y. L. Lee, Y. Y. Chan and T. S. Wu, Phytochemistry, 1998, 48, 743 [Links]. |
|
153
|
|
M. Tomita and S. Sagasawa, J. Pharm. Soc. Japan, 1959, 79, 974, 1470. |
|
154
|
|
Z. L. Chen, B. S. Hang, D. Y. Yu and M. L. Lin, Acta Chem. Sinica, 1981, 39, 237. |
|
155
|
|
H. Tan and Y. Lin, Zhongguo Zhongyao Zazhi, 1994, 19, 677. |
|
156
|
|
T. S. Wu, Y. Y. Chan, Y. L. Leu, P. L. Wu, C. Y. Li and Y. Mori, J. Nat. Prod., 1999, 62, 348 [Links]. |
|
157
|
|
T. S. Wu, Y. Y. Chan, Y. L. Leu and Z. T. Chen, J. Nat. Prod., 1999, 62, 415 [Links]. |
|
158
|
|
T. S. Wu, Y. L. Leu and Y. Y. Chan, Chem. Pharm. Bull., 1998, 46, 1301. |
|
159
|
|
N. De Tommasi, L. Rastrelli and F. De Simone, Nat. Prod. Lett., 1998, 11, 263. |
|
160
|
|
J. X. De Araujo, M. C. De Oliveira Chaves, E. V. L. Da Cunha and A. I. Gray, Biochem. Syst. Ecol., 1999, 27, 325 [Links]. |
|
161
|
|
Y. Sugimoto, S. Inanaga, M. Kato, T. Shimizu, T. Hakoshima and A. Isogai, Phytochemistry, 1998, 49, 1293 [Links]. |
|
162
|
|
H. Guinaudeau, L. Z. Lin, G. A. Cordell and N. Ruangrungsi, Phytochemistry, 1998, 49, 2561163 [Links]. |
|
163
|
|
A. Coop, J. W. Janetka, J. W. Lewis and K. C. Rice, Heterocycles, 1998, 63, 4392. |
|
164
|
|
A. Coop and K. C. Rice, Heterocycles, 1998, 49, 43. |
|
165
|
|
A. Coop and K. C. Rice, Heterocycles, 1998, 49, 39. |
|
166
|
|
K. Görlitzer, I. M. Weltrowski and A. Wright, Pharmazie, 1998, 53, 237. |
|
167
|
|
K. Görlitzer, I. M. Weltrowski and V. Wray, Pharmazie, 1998, 53, 533. |
|
168
|
|
P. Gao, D. L. Larson and P. S. Portoghese, J. Med. Chem., 1998, 41, 3091 [Links]. |
|
169
|
|
M. Liu, M. F. Mahon and M. Sainsbury, J. Chem. Soc., Perkin Trans. 1, 1998, 2943 [Links]. |
|
170
|
|
M. Liu, M. Sainsbury and N. Carter, J. Chem. Soc., Perkin Trans. 1, 1999, 241 [Links]. |
|
171
|
|
K. J. Kim and S. M. Kim, Yakhak Hoechi, 1998, 42, 257. |
|
172
|
|
M. János, S. Garadnay, Z. Szahó, S. Hosztafi and S. Makleit, Acta Chem. Scand., 1998, 52, 1234. |
|
173
|
|
K. Micskei, J. Gyarmati, G. Kovacs, S. Makleit, C. Simon, Z. Szabo, J. Marton, S. Hosztafi, H. Reincke and H. J. Drexler, Eur. J. Org. Chem., 1999, 149 [Links]. |
|
174
|
|
K. Grivas, S. W. Breeden, C. Ganter, S. M. Husbands and J. W. Lewis, Tetrahedron Lett., 1999, 40, 1795 [Links]. |
|
175
|
|
K. W. Bentley, D. G. Hardy, B. Meek, J. B. Taylor, J. J. Brown and G. O. Morton, J. Chem. Soc. C., 1969, 2229 [Links]. |
|
176
|
|
I. Bhakanova, V. N. Nesterov, S. K. Moiseev, H. Schmidhammer and V. N. Kalinin, Russ. Chem. Bull., 1998, 47, 2177. |
|
177
|
|
S. M. Husbands, J. Sadd, J. H. Broadbear, J. H. Woods, J. Martin, J. R. Traynor, M. D. Aceto, E. R. Bowman, L. S. Harris and J. W. Lewis, J. Med. Chem., 1998, 41, 3493 [Links]. |
|
178
|
|
E. L. May, A. E. Jacobson, M. V. Mattson, A. Coop, M. D. Aceto, E. R. Bowman, J. R. Traynor, J. H. Woods and L. S. Harris, Med. Chem. Res., 1998, 8, 311. |
|
179
|
|
H. Schmidhammer, R. Krassnig, E. Greiner and J. R. Traynor, Heterocycles, 1998, 48, 489. |
|
180
|
|
S. Ohkawa and P. S. Portoghese, J. Med. Chem., 1998, 41, 4177 [Links]. |
|
181
|
|
H. Schmidhammer, P. Schwarz and Z. Y. Wei, PCT Int. Appl.
WO2267.98 (Chem. Abstr., 1998, 129, 41303). |
|
182
|
|
H. Schmidhammer, R. Krassnig, E. Greiner, J. Schuetz, A. White and I. P. Berzetei-Gurske, Helv. Chim. Acta, 1998, 81, 1067. |
|
183
|
|
H. Nagase, Y. Imamura, J. Hirokawa, S. Matsuda and Y. Miyauchi,
PCT Int. Appl. WO31684/98 (Chem. Abstr., 1998,
129, 136345). |
|
184
|
|
T. A. Kshirsagar, X. Fang and P. S. Portoghese, J. Med. Chem., 1998, 41, 2657 [Links]. |
|
185
|
|
H. Nagase, I. Imamura, H. Ohno, M. Kameda, S. Matsuda and Y.
Migauchi, PCT Int. Appl. WO43977/98 (Chem. Abstr., 1998,
129, 276082). |
|
186
|
|
M. Varasi, P. Pevarello, G. Traquandi, R. Amici and P. Salvati,
PCT Int. Appl. WO43962/98 (Chem. Abstr., 1998,
129, 290270). |
|
187
|
|
H. Nagase, H. Fujii, T. Endoh and K. Kawai, PCT Int. Appl.
WO43978/98 (Chem. Abstr., 1998, 129, 276083). |
|
188
|
|
J. Marton, S. Szabo, S. Garadnay, S. Miklos and S. Makleit, Tetrahedron, 1998, 54, 9143 [Links]. |
|
189
|
|
J. S. Dung, B. Mudryk, C. Sapino and A. Sebastian, Eur. Pat.
Appl. EP889045/99 (Chem. Abstr., 1999, 130,
110451). |
|
190
|
|
R. Hoffmann, B. Asmussen, A. Koch, T. Hille, B. Adam and R.
Matusch, PCT Int. Appl. WO15528/99 (Chem. Abstr., 1999,
130, 267610). |
|
191
|
|
H. Nagase, K. Ueno, K. Hagimoto, T. Endoh, T. Tanaka, K. Kawamura
and M. Shiraki, PCT. Int. Appl. WO05141/99 (Chem. Abstr.,
1999, 130, 163190). |
|
192
|
|
B. S. Huang, A. Christodoulou, Y. Lu and B. Li, PCT Int.
Appl. WO02529/99 (Chem. Abstr., 1999, 130,
125256). |
|
193
|
|
H. H. Seltzman, M. J. Roche, C. P. Laudeman, C. D. Wyrick and F. R. Carrol, J. Labelled Compd. Radiopharm., 1998, 41, 811 [Links]. |
|
194
|
|
W. B. Matthews, C. M. Kinter, J. Palma, R. V. Daniels, H. T. Ravert, R. F. Dannals and J. R. Lever, J. Labelled Compd. Radiopharm., 1999, 42, 43 [Links]. |
|
195
|
|
K. M. Madyastha, G. V. B. Reddy and G. R. Sridar, Indian J. Chem. Sect. B, 1998, 38, 749. |
|
196
|
|
T. A. Assmundstad and P. Storset, Hum. Exp. Toxicol., 1998, 17, 347. |
|
197
|
|
G. Sakai, K. Ogata, T. Uda, N. Miamura and N. Yamazoe, Sens. Actuators B, 1998, 49, 5 [Links]. |
|
198
|
|
W. J. Liaw, S. T. Ho, J. J. Wang, O. Y. P. Hu and J. H. Li, J. Chromatogr. B; Biomed. Sci. Appl., 1998, 714, 237. |
|
199
|
|
K. F. Buechler, G. E. Valkirs and R. R. Anderson, PCT Int.
Appl. WO57172/98 (Chem. Abstr., 1999, 130,
63345). |
|
200
|
|
B. A. Rashid, G. W. Aherne, M. A. Katineh, P. Kwasowski and D. Stevenson, J. Chromatogr. A, 1998, 797, 245 [Links]. |
|
201
|
|
S. Ji and K. Wang, Zhongcaoyao, 1998, 29, 521. |
|
202
|
|
N. W. Barnett, B. J. Hindson, S. W. Lewis and S. D. Purcell, Anal. Commun., 1998, 35, 321 [Links]. |
|
203
|
|
F. Lagrange, F. Perhourcq, M. Baumevieille and B. Begaud, J. Pharm. Biomed. Anal., 1998, 16, 1295 [Links]. |
|
204
|
|
M. Lutz and A. L. Spek, Acta Crystallogr., Sect. C, 1998, 54, 1477 [Links]. |
|
205
|
|
S. P. Griffiths, P. B. Wells, K. G. Griffin and P. Johnson, Chem. Ind. (Dekker), 1998, 75, 89. |
|
206
|
|
D. Trauner, J. W. Bats, A. Werner and J. Mulzer, J. Org. Chem., 1998, 63, 5908 [Links]. |
|
207
|
|
A. G. Schultz and A. Wang, J. Am. Chem. Soc., 1998, 120, 8259 [Links]. |
|
208
|
|
D. Trauner, S. Porth, T. Opatz, J. W. Bats, G. Giester and J. Mulzer, Synthesis, 1998, 653 [Links]. |
|
209
|
|
H. Loh, H. C. Liu, A. Cavalli, W. Yang, Y. F. Chen and L. N. Wei, Mol. Brain Res., 1998, 54, 321 [Links]. |
|
210
|
|
H. N. Bhargava, V. M. Villar, J. Cortijo and E. J. Morcillo, J. Pharm. Pharmacol., 1998, 50, 197. |
|
211
|
|
S. Tokuyama, M. Inoue, T. Fuchigami and H. Ueda, Life Sci., 1998, 62, 1677 [Links]. |
|
212
|
|
C. Courteix, P. Bourget, F. Caussade, M. Bardin, F. Coudore, J. Fialip and A. Eschalier, J. Pharmacol. Exp. Ther., 1998, 285, 63. |
|
213
|
|
N. Altier and J. Stewart, J. Pharmacol. Exp. Ther., 1998, 285, 208. |
|
214
|
|
P. M. Kunko, D. French and S. Izenniasser, J. Pharmacol. Exp. Ther., 1998, 285, 277. |
|
215
|
|
R. Dallel, C. Duale and J. Molat, J. Neurosci., 1998, 18, 3529. |
|
216
|
|
S. Nikfar, M. Abdollahi, A. Kebriaeezadeh and M. Chitsaz, Gen. Pharmacol., 1998, 31, 55 [Links]. |
|
217
|
|
J. M. Valone, C. K. Randall, P. J. Kaemer and M. T. Bardo, Pharmacol. Biochem. Behav., 1998, 60, 115 [Links]. |
|
218
|
|
B. Manning and K. B. J. Franklin, Behav. Brain Res., 1998, 60, 407. |
|
219
|
|
F. L. Smith, D. Cichewicz, Z. L. Martin and S. P. Welch, Pharmacol. Biochem. Behav., 1998, 60, 559 [Links]. |
|
220
|
|
R. Likar, R. Sitte, K. Gragger, H. Blatnig, C. Breschab, H. V. Scalk, C. Stein and M. Schafer, Pain, 1998, 76, 145 [Links]. |
|
221
|
|
C. Warfield, Cancer (New York), 1998, 82, 2299. |
|
222
|
|
E. K. Krzanowska, G. C. Rossi, G. W. Pasternak and R. J. Bodnar, Brain Res., 1998, 799, 329 [Links]. |
|
223
|
|
Takeshita and I. Yamaguchi, Pharmacol. Biochem. Behav., 1998, 60, 889 [Links]. |
|
224
|
|
S. Nikfar, M. Abdollahi, F. Sarkarati and F. Etemad, Gen. Pharmacol., 1998, 31, 425 [Links]. |
|
225
|
|
A. Bespalov, M. Kudryashova and E. Zvartau, Eur. J. Pharmacol., 1998, 351, 299 [Links]. |
|
226
|
|
A. K. Houghton, J. C. Valdez and K. N. Westhund, Anesthesiology, 1998, 89, 190. |
|
227
|
|
H. N. Bhargava and J. T. Bian, Pharmacol. Biochem. Behav., 1998, 61, 29 [Links]. |
|
228
|
|
F. L. C. P. Machado, J. F. Hurnik and K. K. Ewing, Can. J. Vet. Res., 1998, 62, 218. |
|
229
|
|
B. Everts, B. W. Karlson, J. Herlitz and T. Hedner, Eur. J. Pain, 1998, 2, 115. |
|
230
|
|
N. Kitanaka, I. Sora, S. Kinsey and Z. Zeng, Eur. J. Pharmacol., 1998, 355, R1 [Links]. |
|
231
|
|
K. Xu, Y. Gao, J. Tan and B. Chen, Guandong Yixue, 1998, 119, 446. |
|
232
|
|
F. R. D Amato, Behav. Pharmacol., 1998, 9, 69. |
|
233
|
|
D. Niv, A. Nemirovsky, J. Metzner, V. Rudick, I. Jurna and G. Urca, Anesth. Analg. (Baltimore), 1998, 87, 583. |
|
234
|
|
J. F. Boylan, J. Katz, B. F. Kavanagh, J. R. Klinck, D. C. H. Cheng, W. C. Di Majo, P. M. Walker, K. W. Johnston and A. N. Sandler, Anesthesiology, 1998, 89, 585. |
|
235
|
|
D. Jourdan, D. Ardid, E. Chapuy, D. Le Bars and A. Eschalier, Life Sci., 1998, 63, 1761 [Links]. |
|
236
|
|
H. F. Miranda and G. Pinardi, Pharmacol. Biochem. Behav., 1998, 61, 357 [Links]. |
|
237
|
|
L. Poulsen, L. Riishede, K. Brosen, S. Clemensen and S. H. Sindrup, Eur. J. Clin. Pharmacol., 1998, 54, 451 [Links]. |
|
238
|
|
C. Ripamonti, L. Groff, C. Brunetti, D. Polastri, A. Stavrakis and F. De Conno, J. Clin. Oncol., 1998, 16, 3216. |
|
239
|
|
I. V. Belozertseva and A. Y. Bespalov, Naunyn-Schmiedeberg s Arch. Pharmacol., 1998, 358, 270. |
|
240
|
|
S. L. Guen, G. Catheline and J. M. Besson, Brain Res., 1998, 813, 128 [Links]. |
|
241
|
|
Y. Shen, W. Ma, M. Wang and B. Yu, Shanghai Dier Yike Daxue Xuebao, 1998, 18, 300. |
|
242
|
|
B. Kest, G. McLemore, B. Sadowski, J. S. Mogil, J. K. Belknap and C. E. Inturissi, Neurosci. Lett., 1998, 256, 120 [Links]. |
|
243
|
|
S. Mercadante, A. Casuccio, A. Agnello, R. Serratta, I. Calderone and L. Barresi, J. Clin. Oncol., 1998, 16, 3656. |
|
244
|
|
M. Gardmark, A. U. Hoglund and M. Hammarlund-Udenaes, Pharmacol. Toxicol. (Copenhagen), 1998, 83, 252. |
|
245
|
|
T. Sato, N. Takahashi, K. Tan-No, K. Kisara, T. Sakurada and S. Sakurada, Methods Find. Exp. Clin. Pharmacol., 1998, 20, 581. |
|
246
|
|
K. W. Easterling and S. G. Holtzman, Psychopharmacology (Berlin), 1998, 140, 91. |
|
247
|
|
D. J. Walker and J. P. Zacny, Psychopharmacology (Berlin), 1998, 140, 185. |
|
248
|
|
J. Li, X. Li, G. Pei and Q. B. Yi, Zhongguo Yaoli Xuebao, 1999, 20, 81. |
|
249
|
|
K. H. Leung, C. T. Huang, C. F. Fung and A. C. Y. Lo, Int. Congr. Ser.-Excerpta Med., 1998, 1164, 341. |
|
250
|
|
M. A. S. Baptista, S. Siegel, G. MacQueen and L. T. Young, NeuroReport, 1998, 9, 3387. |
|
251
|
|
A. Haghparast, S. Sembanian and Y. Fathollahi, Brain Res., 1998, 814, 71 [Links]. |
|
252
|
|
J. Lotsch, G. Kobal and G. Gesslinger, Clin. Neuopharmacol., 1998, 21, 351. |
|
253
|
|
M. Choiniere, B. E. Rittenhouse, S. Perreault, D. Chartrand, P. Rousseau, B. Smith and C. Pepler, Anesthesiology, 1998, 89, 1377. |
|
254
|
|
T. P. Piepponen, A. Zharkowsky, T. Kivastik and L. Ahtee, Eur. J. Pharmacol., 1999, 365, 159 [Links]. |
|
255
|
|
J. G. Klamt, L. V. Garcia and W. A. Prado, Anaesthesia, 1999, 54, 27 [Links]. |
|
256
|
|
C. M. Craig, S. Emerson, D. Volgoropoulos and D. Alves, Anesthesiology, 1999, 90, 437. |
|
257
|
|
B. Evets, B. Karlson, N. J. Abdon, J. Herlitz and T. Hedner, J. Intern. Med., 1999, 245, 133 [Links]. |
|
258
|
|
J. Y. Li, C. H. Wong, K. S. Huang, K. W. Liang, M. Y. Lin, P. P. C. Tan and J. C. Chen, Life Sci., 1999, 64, PL111 [Links]. |
|
259
|
|
K. Lutfy, P. Doan, M. Nguyen and E. Weber, Pharmacol. Res., 1998, 38, 353 [Links]. |
|
260
|
|
E. K. Krzanowska and R. J. Bodnar, Brain Res., 1999, 821, 224 [Links]. |
|
261
|
|
T. Aasmundstad and J. Morland, Pharmacol. Toxicol. (Copenhagen), 1998, 82, 272. |
|
262
|
|
Z. Xu, J. Wu, B. Wang and W. Wang, Huaxi Yike Daxue Xuebao, 1998, 29, 29. |
|
263
|
|
E. Beyssac, F. Touaref, M. Meyer, L. Jacobs, P. Sabdouk and J. M. Aiache, Biopharm. Drug Dispos., 1998, 19, 401 [Links]. |
|
264
|
|
G. K. Gourlay, Clin. Pharmacokinet., 1998, 35, 173. |
|
265
|
|
C. Pauli-Magnus, U. Hofmann, G. Mikus, U. Kuhlmann and T. Mettang, Nephrol. Dial. Transplant., 1999, 14, 903 [Links]. |
|
266
|
|
C. K. Randall, P. J. Kraemer and M. T. Bardo, Pharmacol. Biochem. Behav., 1998, 60, 212 [Links]. |
|
267
|
|
R. Pilar, F. R. de Fonseca, J. L. Martin-Calderson, I. Del Arco, S. Bartolone, M. A. Villanua and M. Navarro, Pharmacol. Biochem. Behav., 1998, 61, 229 [Links]. |
|
268
|
|
T. Suzuki, Y. Kishimoto, M. Misawa, H. Nagase and F. Takeda, Life Sci., 1999, 64, PL1 [Links]. |
|
269
|
|
E. S. Brodkin, T. A. Kosten, C. N. Haile, G. R. Heninger, W. A. Carlezon, P. Jatlow, E. F. R. Remmers, R. Wilder and E. J. Nestler, Neuroscience (Oxford), 1999, 88, 1307. |
|
270
|
|
A. Zurita and V. Molina, Physiol. Behav., 1999, 65, 833 [Links]. |
|
271
|
|
R. D. Mellon and B. M. Bayer, J. Neuroimmunol., 1998, 83, 19 [Links]. |
|
272
|
|
D. M. Hall, J. L. Suo and R. J. Weber, J. Neuroimmunol., 1998, 83, 29 [Links]. |
|
273
|
|
T. K. Eisenstein and M. E. Hilburger, J. Neuroimmunol., 1998, 83, 36 [Links]. |
|
274
|
|
T. K. Eisenstein, T. S. Rogers, J. J. Messker, M. W. Adler and M. E. Hilburger, Adv. Exp. Med. Biol., 1998, 437, 33. |
|
275
|
|
M. E. Coussons-Read, M. Daniels and M. I. Gilmour, Adv. Exp. Med. Biol., 1998, 437, 73. |
|
276
|
|
G. D. Wu, J. A. Graf, J. E. Zadna and S. L. Chang, Adv. Exp. Med. Biol., 1998, 437, 51. |
|
277
|
|
J. T. Martin, S. L. Nehlsen-Cannarella, G. M. Gugelchuk and O. R. Fagoaga, Adv. Exp. Med. Biol., 1998, 437, 149. |
|
278
|
|
S. Roy, K. J. Cain, R. B. Chapin, R. G. Charboneau and R. A. Barke, Biochem. Biophys. Res. Commun., 1998, 245, 392 [Links]. |
|
279
|
|
T. Sills and F. J. Vaccarino, Pharmacol. Biochem. Behav., 1998, 60, 293 [Links]. |
|
280
|
|
R. A. Bevis and M. T. Bardo, Exp. Clin. Psychopharmacol., 1998, 6, 131 [Links]. |
|
281
|
|
A. Dogrul and O. Yesilyurt, Eur. J. Pharmacol., 1999, 364, 175 [Links]. |
|
282
|
|
V. Prevot, C. M. Rialas, D. Croix, M. Salzet, T. P. Dupouy, P. Poulain, J. C. Beauvillain and G. B. Stephano, Brain Res., 1998, 790, 236 [Links]. |
|
283
|
|
T. Mori, K. Nishikawa, T. Terai, H. Yukioka and A. Asada, Anesthesiology, 1998, 88, 1558. |
|
284
|
|
L. D. Napier, A. Stanfill, D. A. Yoshishige, K. E. Jackson and B. A. Barron, Am. J. Physiol., 1998, 275, H2199. |
|
285
|
|
T. Asai, Arzneim.-Forsch., 1998, 48, 802. |
|
286
|
|
C. S. Yuan, J. F. Foss, M. O Connor, M. F. Roizen and J. Moss, J. Clin. Pharmacol., 1998, 38, 1017. |
|
287
|
|
B. L. Neudeck and K. M. Smith, J. Pharm. Technol., 1998, 14, 53. |
|
288
|
|
A. Osterlund, E. Arlander, L. I. Erikson and S. G. E. Lindahl, Anesth. Analg (Baltimore), 1999, 88, 160. |
|
289
|
|
S. Yang and K. A. Follett, Brain Res., 1998, 808, 101 [Links]. |
|
290
|
|
W. Wongchanapai, B. K. Tsang, Z. He and I. K. Ho, Pharmacol. Biochem. Behav., 1998, 60, 899 [Links]. |
|
291
|
|
M. Bakke, J. W. Hu and B. J. Sessle, NeuroReport, 1998, 9, 3315. |
|
292
|
|
J. F. Coetzee and H. Van Loggerenberg, Br. J. Anaesth., 1998, 81, 731. |
|
293
|
|
F. A. Mansouri, F. Motamedi and Y. Fathollahi, Brain Res., 1999, 815, 419 [Links]. |
|
294
|
|
S. Khanna and F. Zeng, Neuroscience (Oxford), 199, 89, 61. |
|
295
|
|
Y. Shavit, E. Cohen, R. Gagin, R. Avitsur, Y. Pollak, G. Chaikin, G. Wolf and R. Yirmiya, Pharmacol. Biochem. Behav., 1998, 59, 835 [Links]. |
|
296
|
|
I. Vathy, J. Veliskova and S. L. Moshe, Pharmacol. Biochem. Behav., 1998, 60, 635 [Links]. |
|
297
|
|
S. Roy, K. J. Cain, R. G. Charboneau and R. A. Barke, Adv. Exp. Med. Biol., 1998, 437, 21. |
|
298
|
|
B. Plytycz, M. Chadzinska, J. Mika, D. Labuz and B. Przewlocka, Pol. J. Pharmacol., 1998, 50, 271. |
|
299
|
|
K. P. Mayfield, A. Kozak, K. Rudolph and M. J. Kluger, Ann. N. Y. Acad. Sci., 1998, 865, 286. |
|
300
|
|
T. L. Wang, H. Chang, C. R. Huang and Y. Z. Tseng, Cardiovasc. Res., 1998, 40, 557 [Links]. |
|
301
|
|
R. D. Mellon and B. M. Bayer, J. Pharmacol. Exp. Ther., 1999, 288, 438. |
|
302
|
|
G. de Araujo-Lucas, P. Alster, E. Brodin and Z. Wiesenfeld-Hallin, Neurosci. Lett., 1998, 244, 13 [Links]. |
|
303
|
|
G. de Araujo-Lucas, O. Hoffmann, P. Alster and Z. Wiesenfeld-Hallin, Brain Res., 1999, 821, 79 [Links]. |
|
304
|
|
H. L. Kimmel, J. B. Justice and S. G. Holtzman, Eur. J. Pharmacol., 1998, 346, 203 [Links]. |
|
305
|
|
M. F. Olive and N. T. Maidment, J. Pharmacol. Exp. Ther., 1998, 285, 1310. |
|
306
|
|
S. Lindow, M. S. Hendricks, J. W. Thompson and Z. M. Van der Spuy, Clin. Sci., 1998, 95, 91. |
|
307
|
|
S. Chakrabarti, L. Wang, W. J. Tang and A. R. Gintzler, Mol. Pharmacol., 1998, 54, 949. |
|
308
|
|
N. Kanaya, D. R. Zakhary, P. A. Murray and D. S. Damron, Anesthesiology, 1998, 89, 1532. |
|
309
|
|
M. Gaiardi, M. Bartoletti and C. Gunellini, Pharmacol. Res., 1998, 38, 333 [Links]. |
|
310
|
|
Y. Y. Chia, P. H. Tan, K. Y. Wang and K. Liu, Eur. J. Anaesthesiol., 1998, 15, 664 [Links]. |
|
311
|
|
G. A. Tejwani, M. J. Sheu, P. Sribanditmongkol and A. Satyapriya, Brain Res., 1998, 797, 305 [Links]. |
|
312
|
|
W. A. Watson, M. T. Steele, R. L. Muelleman and M. D. Rush, J. Toxicol. Clin. Toxicol., 1998, 36, 11 [Links]. |
|
313
|
|
P. J. Fulda, E. Yu, W. Macfadden, C. Boardman and C. C. Nora, Drug Alcohol Depend., 1998, 50, 1 [Links]. |
|
314
|
|
P. Enrico, M. Mura, G. Esposito, P. Serra, R. Migheli, G. De Natale, M. Desole, R. Miele and E. Miele, Brain Res., 1998, 797, 94 [Links]. |
|
315
|
|
L. A. Parker and A. Joshi, Pharmacol. Biochem. Behav., 1998, 61, 331 [Links]. |
|
316
|
|
J. J. Wang, S. T. Ho and J. I. Tzeng, Reg. Anesth. Pain Med., 1998, 23, 474. |
|
317
|
|
M. I. Rosen, R. H. Pearsall and T. R. Kosten, Drug Alcohol Depend., 1998, 52, 135 [Links]. |
|
318
|
|
A. H. Oliveto, M. I. Rosen, T. A. Kosten, F. A. Hameedi, S. W. Woods and T. R. Kosten, Exp. Clin. Psychopharmacol., 1998, 6, 169 [Links]. |
|
319
|
|
A. F. Martin-Del Campo, J. Cortez-Sotres, K. Herrera-Ferra and A. Ulloa-Aguirre, Psychoneuroendocrinology, 1998, 23, 413 [Links]. |
|
320
|
|
S. Higgs and S. J. Cooper, Psychopharmacology (Berlin), 1998, 139, 341. |
|
321
|
|
G. C. Abrahamsen, B. J. Caldarone and H. S. Stock, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 1998, 22, 1303. |
|
322
|
|
C. Belzung and D. Dubreuil, Behav. Pharmacol., 1998, 9, 691. |
|
323
|
|
M. J. Glass, E. O Hare, J. P. Cleary, C. J. Billington and A. S. Levine, Psychopharmacology (Berlin), 1999, 141, 378. |
|
324
|
|
H. E. Makulska-Nowak, S. W. Gumulka and S. Kolaric, Analgesia (Elmsford, N. Y.), 1998, 3, 291. |
|
325
|
|
L. N. Du, J. W. Jiang, G. C. Wu and X. D. Cao, Shengli Xuebao, 1998, 50, 636. |
|
326
|
|
K. C. Crisanti and J. E. Fewell, J. Appl. Physiol., 1998, 85, 1150. |
|
327
|
|
J. Zhu, H. W. Wang and W. X. Yao, Hunan Yixue, 1998, 15, 124. |
|
328
|
|
J. R. Sheu, Y. Lee, L. W. Lee, H. N. Luk and M. H. Yen, Clin. Exp. Pharmacol. Physiol., 1998, 25, 585 [Links]. |
|
329
|
|
L. Li, Shaanxi Yixue Zazhi, 1998, 27, 162. |
|
330
|
|
J. Hengzhong, Hunan Yixue, 1998, 15, 309. |
|
331
|
|
J. M. Joyner, J. E. Grice, G. I. Hockings, D. J. Torpy, G V. Crosbie, M. M. Walters and R. V. Jackson, J. Neuroendocrinology, 1998, 10, 391. |
|
332
|
|
X. Luo, X. Zhang, H. Chang, J. Wang and Y. Wang, Yanbian Daxue Yixue Xuebao, 1998, 21, 79. |
|
333
|
|
R. M. Vigneras, P. Medina, G. Reyes, J. C. Rojas and M. De La Luz Rosales, Proc. West. Pharmacol. Soc., 1998, 41, 41. |
|
334
|
|
T. Asai and I. Power, Anesth. Analg. (Baltimore), 1999, 88, 204. |
|
335
|
|
S. L. Liu and J. T. Zhang, Zhongguo Yaoli Xuebao, 1999, 20, 112. |
|
336
|
|
S. W. Husaini and I. F. Russell, Br. J. Anaesth., 1998, 81, 135. |
|
337
|
|
J. J. Rady, G. I. Elner and J. M. Fujimoto, J. Pharmacol. Exp. Ther., 1999, 288, 438. |
|
338
|
|
J. P. Laulin, E. Celerier, A. Larcher, M. Le Moal and G. Simonnet, Neuroscience (Oxford), 1999, 89, 631. |
|
339
|
|
A. G. P. Schuller, M. A. King, J. Zhang, E. Bolan, Y. X. Pan, D. J. Morgan, A. Choang, M. E. Czick and E. M. Unterwald, Nat. Neurosci., 1999, 2, 151 [Links]. |
|
340
|
|
M. Gardmark, M. O. Karlsson, F. Jonsson and M. Hammarlund-Udensa, J. Pharm. Sci., 1998, 87, 813 [Links]. |
|
341
|
|
J. Lotsch, M. Weiss, G. Kobal and G. Geisslinger, Clin. Pharmacol. Ther. (St. Louis), 1998, 63, 629. |
|
342
|
|
L. Leventhal, R. M. Silva, G. C. Rossi, G. W. Pasternak and R. J. Bodnar, J. Pharmacol. Exp. Ther., 1998, 287, 538. |
|
343
|
|
N. Katori, N. Aoyagi and S. Kojima, Biol. Pharm. Bull., 1998, 21, 418. |
|
344
|
|
J. Ruan, H. Li, F. Han, H. Wei, S. Liu and Z. Cai, Zhongguo Linchuang Yaolixue Zazhi, 1997, 13, 134. |
|
345
|
|
P. A. Moore, R. J. Crout, D. L. Jackson, L. G. Schneider, R. W. Graves and R. Bakos, J. Clin. Pharmacol., 1998, 38, 554. |
|
346
|
|
S. R. Y. Herberg, M. L. Mahowald and S. R. Woods, Arthritis Rheum., 1998, 41, 1603. |
|
347
|
|
Y. Yue, J. Hasselstrom, J. O. Svensson and J. Sawe, Eur. J. Clin. Pharmacol., 1999, 54, 839 [Links]. |
|
348
|
|
V. Srinivasan, D. Wielbo and I. R. Tebbett, Eur. J. Pain, 1997, 1, 85Chem. Abstr.1999130306461. |
|
349
|
|
A. W. E. Wright, M. L. Nocente and M. T. Smith, Life Sci., 1998, 63, 401 [Links]. |
|
350
|
|
M. D. Aceto, L. S. Harris and M. E. Abood, Eur. J. Pharmacol., 1999, 365, 143 [Links]. |
|
351
|
|
M. P. Gomez-Serranillos, O. M. Palomino, E. Carretero and A. Villar, Phytother. Res., 1998, 12, 346 [Links]. |
|
352
|
|
C. P. N. Watson and N. Babul, Neurology, 1998, 50, 1837. |
|
353
|
|
P. Tanskanen, J. Kytta and T. Randell, Acta Anaesth. Scand., 1999, 43, 42. |
|
354
|
|
P. A. Muittari, O. Nelimarkka, T. Seppala, J. H. Kanto and O. A. Kirvela, J. Clin. Anesth., 1999, 11, 11 [Links]. |
|
355
|
|
B. Kest, C. E. Lee, S. Jenab, B. Kao and C. E. Inturrisi, Eur. J. Pharmacol., 1998, 345, 47 [Links]. |
|
356
|
|
I. M. Salloum, J. R. Cornelius, M. E. Thase, D. C. Daley, L. Kirisci and C. Spotts, Psychopharmacol. Bull., 1998, 34, 111. |
|
357
|
|
J. H. Liles, P. A. Flecknell, J. Roughan and I. Cruz-Madorran, Lab. Anim., 1998, 32, 149. |
|
358
|
|
S. Kim and M. D. Won, J. Clin. Psychiatry, 1998, 59, 159. |
|
359
|
|
M. J. Sernyak, W. M. Glazer, G. R. Heninger, D. S. Chaney, S. W. Woods, I. L. Petrakis, J. H. Krystal and I. H. Price, J. Clin. Psychopharmacol., 1998, 18, 248 [Links]. |
|
360
|
|
T. A. G. Briggs and R. D. Myers, Pharmacol. Biochem. Behav., 1998, 60, 407 [Links]. |
|
361
|
|
T. Sir-Petermann, G. Lopez, T. Castillo, M. Calvillan, B. Rabenbauer and L. Wildt, Exp. Clin. Endocrinol. Diabetes, 1998, 106, 389. |
|
362
|
|
D. Hersh, J. R. Van Kirk and H. Kranzler, Psychopharmacology (Berlin), 1998, 139, 44. |
|
363
|
|
L. D. Mitchen, C. K. Kruschel, E. Dallman, K. A. Anders, M. Czapigan, J. J. Panos and R. E. Steinpreis, Pharmacol. Biochen. Behav., 1999, 62, 97. |
|
364
|
|
M. E. Wewers, R. Dhatt and G. A. Tejwani, Psychopharmacology (Berlin), 1998, 140, 185. |
|
365
|
|
A. Ferrari, M. Bertoletti, U. Avico and E. Sternieri, Drug Alcohol Dispos., 1998, 52, 211. |
|
366
|
|
D. Davidson, T. Palfai, C. Birol and R. Swift, Alcohol: Clin. Exp. Res., 1999, 23, 195. |
|
367
|
|
J. F. Foss, C. S. Yuan, M. F. Roizen and L. I. Goldberg, Cancer Chemother. Pharmacol., 1998, 42, 287. |
|
368
|
|
C. S. Yuan, J. F. Foss, M. O Connor, J. Osinski, M. F. Roizen and J. Moss, Drug Alcohol Depend., 1998, 52, 161 [Links]. |
|
369
|
|
D. B. Murphy and M. B. Murphy, J. Cardiovasc. Pharmacol., 1999, 33, 122 [Links]. |
|
370
|
|
K. M. Linner, B. J. Stickney, H. E. Quist and B. M. Sharp, Eur. J. Pharmacol., 1998, 354, R3 [Links]. |
|
371
|
|
B. Fernandez, M. A. Antelo, C. Guaza, I. Alberti, M. L. Pinillos and M. P. Viveros, Dev. Brain Res., 1999, 112, 135 [Links]. |
|
372
|
|
B. Fernandez, I. Alberti, I. Kitchen and M. P. Viveros, Neurosci. Lett., 1999, 260, 81 [Links]. |
|
373
|
|
T. Assi, W. W. Mapleson and I. Power, Br. J. Anaesth., 1998, 80, 814. |
|
374
|
|
J. J. Wang, S. T. Ho, S. C. Lee and Y. C. Liy, Anesth. Analg. (Baltimore), 1999, 88, 686. |
|
375
|
|
A. A. Van den Berg, L. F. Montoya-Pelaez, E. H. Halliday, I. Hasson and M. S. Baloch, Eur. J. Anaesthesiol., 1999, 16, 186 [Links]. |
|
376
|
|
J. H. Schluger, A. Ho, L. Borg, M. Porter, S. Maniar, M. Grunduz, G. Perret, A. King and M. J. Kreek, Alcohol: Clin. Exp. Res., 1998, 22, 1430. |
|
377
|
|
N. Takahashi, S. Sakurada, A. Yonezawa, K. Arai, T. Sato, S. Kawamura, F. Niijima and K. Kisara, Ann. Rept. Tohoku Coll. Pharm., 1997, 44, 241Chem. Abstr.199913020517. |
|
378
|
|
T. J. Martin, M. G. De Montis, S. A. Kim, G. M. Sizemore, S. I. Dworkin and J. E. Smith, Drig Alcohol Depend., 1998, 52, 135. |
|
379
|
|
D. Morgan and M. J. Picker, Psychopharmacology (Berlin), 1998, 140, 20. |
|
380
|
|
M. M. Puig and O. Pol, J. Pharmacol. Exp. Ther., 1998, 287, 1068. |
|
381
|
|
K. L. Williams and J. H. Woods, Alcohol: Clin. Exp. Res., 1998, 22, 1634. |
|
382
|
|
A. Coop and A. E. Jacobson, Bioorg. Med. Chem. Lett., 1999, 9, 357 [Links]. |
|
383
|
|
L. Amass, W. K. Bickel, J. P. Crean, J. Blake and S. T. Higgins, Psychopharmacology (Berlin), 1998, 136, 217. |
|
384
|
|
P. Tauzin-Fin, S. Delort-Laval, M. C. Krol-Houdek, P. Maurette and B. Bannworth, Eur. J. Anaesthesiol., 1998, 15, 147 [Links]. |
|
385
|
|
F. Kugawa, K. Arae, A. Ueno and M. Aoki, Eur. J. Pharmacol., 1998, 347, 105 [Links]. |
|
386
|
|
M. Gaiardi, C. Gubellini and M. Bartholetti, Pharmacol. Res., 1998, 37, 303 [Links]. |
|
387
|
|
D. Banerjee and N. K. Sarka, Folia Biol. (Krakow), 1997, 45, 157Chem. Abstr.1998129170365. |
|
388
|
|
K. Kobayashi, T. Yamamoto, K. Chiba, M. Tani, N. Shimada, T. Ishiaki and Y. Kuriowa, Drug Metab. Dispos., 1998, 26, 818. |
|
389
|
|
K. D. Natwi, S. Hicks, D. Bradley and E. P. Schoener, Gen. Pharmacol., 1998, 31, 425 [Links]. |
|
390
|
|
P. G. O Connor, A. H. Olivet, J. M. Shi, E. G. Triffleman, R. M. Carroll, T. R. Kosten, B. J. Rounsaville, J. A. Pakes and R. B. Schottenfeld, Ann. J. Med., 1998, 105, 100. |
|
391
|
|
M. O. Szoke, D. Blais, S. G. Cuvelliez and J. P. Lavoie, Am. J. Vet. Res., 1998, 59, 1287. |
|
392
|
|
M. A. Smith and M. J. Picker, Psychopharmacology (Berlin), 1998, 140, 57. |
|
393
|
|
M. Yu, X. Chen and Z. Pi, Hunan Yixue, 1998, 15, 305. |
|
394
|
|
X. Lu, F. Zhang and M. Huang, Zhongguo Yaolixue Yu Dulixue Xuebao, 1997, 11, 275. |
|
395
|
|
R. Vieregger, T. Resch and V. Kaever, Planta Med., 1999, 65, 80. |
|
396
|
|
S. Lei, L. M. Orensanz, M. J. Mulvany and U. Simonsen, Eur. J. Pharmacol., 1999, 365, 193 [Links]. |
|
397
|
|
U. Berg and H. Bladh, Helv. Chim. Acta, 1999, 82, 323 [Links]. |
|
398
|
|
L. Lebeau, P. Ducray and C. Mioskowski, Synth. Commun., 1998, 27, 293. |
|
399
|
|
R. Brecht, F. Haenel, G. Seitz, G. Frenzez, A. Pilz and D. Guenard, Eur. J. Org. Chem., 1998, 2451 [Links]. |
|
400
|
|
J. Guan, A. Brossi, X. K. Zhu, H. K. Wang and K. H. Lee, Synth. Commun., 1998, 28, 1585 [Links]. |
|
401
|
|
M. Cavazza and F. Pietra, Tetrahedron, 1998, 54, 14059 [Links]. |
|
402
|
|
Q. Shi, K. Chen, A. Brossi, P. Verdier-Pinard, E. Hamel, A. T. McPhail and K. H. Lee, Helv. Chim. Acta, 1998, 81, 1023 [Links]. |
|
403
|
|
Q. Shi, K. Chen, X. Chen, A. Brossi, P. Verdier-Pinard, E. Hamel, A. T. McPhail, A. Tropsha and K. H. Lee, J. Org. Chem., 1998, 63, 4018 [Links]. |
|
404
|
|
H. He, F. Liu, Q. Li, J. Lin, M. Li and S. Ji, Yunnan Daxue Xuebao Ziran Kexueban, 1998, 389. |
|
405
|
|
J. Guan, X. K. Zhu, Y. Tachibana, K. F. Bastow, A. Brossi, E. Hamel and K. H. Lee, Bioorg. Med. Chem., 1998, 6, 2127 [Links]. |
|
406
|
|
E. Bombardelli, Eur. Pat. Appl. EP870761/98 (Chem.
Abstr., 1998, 129, 290269). |
|
407
|
|
M. Sobh and M. Ghoneim, Nephron, 1998, 79, 452. |
|
408
|
|
R. Rodriguez, J. Cerbon-Ambritz and M. De Lourdes Munoz, Arch. Med. Res., 1998, 29, 109. |
|
409
|
|
M. Selman, G. Carrillo, J. Salas, R. P. Padilla, R. Perez-Chavira, R. Sansores and R. Chapela, Chest, 1998, 114, 507. |
|
410
|
|
N. Cougnon-Aptel, G. T. Whiteside and R. Munglani, Neurosci. Lett., 1999, 259, 45 [Links]. |
|
411
|
|
A. J. Fischer, I. G. Morgan and W. K. Stell, Vision Res., 1999, 39, 685 [Links]. |
|
412
|
|
A. C. Cicogna, K. G. Robinson, C. H. Conrad, K. Singh, R. Squire, M. P. Okoshi and O. H. L. Bing, Hypertension, 1999, 33, 60. |
|
413
|
|
O. Yu. Balenkov, V. V. Aleksandrov, Z. E. Enikeeva and N. K. Muratkhodzhaev, Dokl. Akad. Nauk Resp. Uzb., 1997, 40Chem. Abstr.199913060663. |
|
414
|
|
Q. H. Shi, I. D. Adler, G. Schriever-Schwemmer, X. Zhang and Y. Chen, Xibao Shengwuxe Zazhi, 1998, 18, 172. |
|
415
|
|
H. Tanaka, T. Tanaka and H. Etoh, Phytochemistry, 1998, 48, 1461 [Links]. |
|
416
|
|
J. Cassayre, B. Quiclet-Sire, J. B. Saunier and S. Z. Zard, Tetrahedron Lett., 1998, 38, 8995 [Links]. |
|
417
|
|
J. Toda, Y. Niimura, T. Sane and Y. Tsuda, Heterocycles, 1998, 48, 1599. |
|
418
|
|
K. Mohri, K. Isobe, M. Maeda, T. Takeda, R. Ohkubo and T. Tsuda, Chem. Pharm. Bull., 1998, 46, 1872. |
|
419
|
|
J. Du, M. Qiu, R. Nie, Y. Lu, N. Wu and Q. Zheng, Tianran Chanwu Yanjiu Yu Kaifa, 1997, 9, 19Chem. Abstr.199913063637. |
|
420
|
|
M. Ikeda, K. Hiroso, S. A. A. El Bialy, T. Sato, Y. Yakura and S. M. M. Bayomi, Chem. Pharm. Bull., 1998, 46, 1084. |
|
421
|
|
L. Beall and A. Padwa, Tetrahedron Lett., 1998, 39, 4159 [Links]. |
|
422
|
|
M. Fang, H. Zhang, S. Xue, N. Li and L. Wang, Cancer Lett. (Shannon), 1998, 127, 113. |
|
423
|
|
S. Liang, X. Yang, A. Peng and Y. Wang, Jiepou Xuebao, 1009, 29, 190. |
|
424
|
|
W. F. Tinto, Heterocycles, 1998, 48, 2089. |
|
425
|
|
E. Sugino, T. Choshi and S. Hibino, Heterocycles, 1999, 50, 543. |
|
426
|
|
G. Valoti, M. Nicoletti, A. Pellegrino, J. Jimeno, H. Hendriks, M. D Incalci, G. Faircloth and R. Givazzi, Clin. Cancer Res., 1999, 4, 1977. |